Literature DB >> 34306481

Correlation analysis between rim enhancement features of contrast-enhanced ultrasound and lymph node metastasis in breast cancer.

Yanling Guo1, Qingfei Song1, Qiaohong Pan1.   

Abstract

OBJECTIVE: To explore the correlation between rim enhancement features of contrast-enhanced ultrasound and lymphatic metastasis, and to provide theoretical support for clinical treatment of breast cancer.
METHODS: 387 breast cancer patients (748 axillary lymph nodes in total) treated in our hospital from January 2017 to January 2020 were selected and analyzed by contrast-enhanced ultrasound. Pathological examination showed that 540 axillary lymph nodes showed metastasis whereas 208 axillary lymph nodes did not show metastasis. Univariate analysis and Logistic stepwise regression were used to analyze the correlation between rim enhancement features of contrast-enhanced ultrasound and axillary lymph node metastasis of breast cancer.
RESULTS: Peripheral halo, peripheral convergence, rim enhancement, enhancement mode, enhancement amplitude, enhancement sequence, expansion after enhancement, peak intensity, time to peak, area under curve, thrombolysis in myocardial infarction, perfusion sequence, aspect ratio, and maximum cortical thickness were all related to lymph node metastasis of breast cancer by univariate analysis, and the difference was statistically significant (P < 0.05). Multivariate analysis showed that enhancement mode, enhancement amplitude, extension after enhancement, maximum cortical thickness, peak intensity and time to peak were all related to lymph node metastasis of breast cancer.
CONCLUSION: Rim enhancement features of contrast-enhanced ultrasound of breast cancer are related to lymph node metastasis, which will provide a guidance for clinical treatment of breast cancer. AJTR
Copyright © 2021.

Entities:  

Keywords:  Breast cancer; contrast enhanced ultrasound; lymph node metastasis; relevance

Year:  2021        PMID: 34306481      PMCID: PMC8290713     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  25 in total

1.  Distribution of lymph node metastasis and the extent of lymph node dissection in descending colon cancer patients.

Authors:  Soo Young Lee; Seung-Seop Yeom; Chang Hyun Kim; Young Jin Kim; Hyeong Rok Kim
Journal:  ANZ J Surg       Date:  2019-08-26       Impact factor: 1.872

2.  Pelvic lymph node metastasis in extramammary Paget disease of the scrotum without inguinal lymph node metastasis.

Authors:  Mari Hioki; Akifumi Ohshita; Sachiyo Yoshida; Fuminao Kanehisa; Norito Katoh; Jun Asai
Journal:  Australas J Dermatol       Date:  2018-11-18       Impact factor: 2.875

3.  Impact of immunodeficiency on lingual carcinogenesis and lymph node metastasis in mice.

Authors:  Shan Wang; Fang Li; Dongxia Qiang; Zheng Hu; Yan Meng; Lei Shi; Eryang Zhao; Yumei Niu
Journal:  J Oral Pathol Med       Date:  2019-08-23       Impact factor: 4.253

4.  Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.

Authors:  Vera Sorin; Yael Yagil; Ady Yosepovich; Anat Shalmon; Michael Gotlieb; Osnat Halshtok Neiman; Miri Sklair-Levy
Journal:  AJR Am J Roentgenol       Date:  2018-09-21       Impact factor: 3.959

5.  Breast hamartoma: Ultrasound, elastosonographic, and contrast-enhanced ultrasound features.

Authors:  Gang Liu; Zhi Li Wang; Meng Ke Zhang; Yan He; Yuan Liu
Journal:  J Cancer Res Ther       Date:  2019       Impact factor: 1.805

6.  Diagnostic and prognostic values of contrast‑enhanced ultrasound combined with diffusion‑weighted magnetic resonance imaging in different subtypes of breast cancer.

Authors:  Gui-Feng Liu; Zong-Qiang Wang; Shu-Hua Zhang; Xue-Feng Li; Lin Liu; Ying-Ying Miao; Shao-Nan Yu
Journal:  Int J Mol Med       Date:  2018-03-27       Impact factor: 4.101

7.  Comparison of Estrogen and Progesterone Receptor Status in Tumor Mass and Axillary Lymph Node Metastasis in Patients with Carcinoma Breast.

Authors:  Shikha Singh; Samarth Shukla; Ashok Singh; Sourya Acharya; R P Kadu; Arvind Bhake
Journal:  Int J Appl Basic Med Res       Date:  2020-04-02

Review 8.  Contrast-enhanced MRI for breast cancer screening.

Authors:  Ritse M Mann; Christiane K Kuhl; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2019-01-18       Impact factor: 4.813

9.  Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.

Authors:  Jung Ok Lee; Min Ju Kang; Won Seok Byun; Shin Ae Kim; Il Hyeok Seo; Jeong Ah Han; Ji Wook Moon; Ji Hae Kim; Su Jin Kim; Eun Jung Lee; Serk In Park; Sun Hwa Park; Hyeon Soo Kim
Journal:  Breast Cancer Res       Date:  2019-10-22       Impact factor: 6.466

10.  Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis.

Authors:  Li Wang; Yang Hong; Jie Ma; Meng Han; Shuo Zhang; Baoen Shan; Yunjiang Liu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.